Growth Metrics

Neuraxis (NRXS) Change in Accured Expenses (2022 - 2025)

Neuraxis (NRXS) has disclosed Change in Accured Expenses for 4 consecutive years, with $536745.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 196.53% to $536745.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 14.01% year-over-year, with the annual reading at $1.1 million for FY2025, 14.01% up from the prior year.
  • Change in Accured Expenses hit $536745.0 in Q4 2025 for Neuraxis, up from $138170.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $592114.0 in Q2 2024 to a low of -$755499.0 in Q3 2023.
  • Historically, Change in Accured Expenses has averaged $124586.1 across 4 years, with a median of $155136.5 in 2023.
  • Biggest YoY gain for Change in Accured Expenses was 645.19% in 2023; the steepest drop was 7233.52% in 2023.
  • Year by year, Change in Accured Expenses stood at $16241.0 in 2022, then skyrocketed by 645.19% to $121027.0 in 2023, then skyrocketed by 49.56% to $181007.0 in 2024, then skyrocketed by 196.53% to $536745.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for NRXS at $536745.0 in Q4 2025, $138170.0 in Q3 2025, and $251028.0 in Q2 2025.